• To transform the clinical research landscape by building and strengthening partnerships between clinical investigators and the communities where their patients reside.
• To facilitate an approach to clinical and translational research that is community-informed, designed and conducted.
• Provide training and resources to build a network of 250 new clinical investigators with community engagement and research skills.
• Expand the number of community-based sites with the capacity to conduct clinical and translational research.
Increased participation of diverse patients in clinical and translational research.
Improved public health through an increase in the development of new drugs, vaccines and therapeutic products that are effective in all populations.
Copyright © 2022
Robert A. Winn Diversity in Clinical Trials Award Program. All Rights Reserved.